细胞毒性T细胞
抗原
肿瘤微环境
生物
免疫系统
癌症研究
白细胞介素21
免疫学
T细胞
抗原提呈细胞
白细胞介素3
表型
细胞生物学
癌症免疫疗法
抗原呈递
肿瘤抗原
免疫疗法
癌细胞
CD40
体外
癌症
功能(生物学)
作者
Thomas N. Burn,Jan Schröder,Luke C. Gandolfo,Maleika Osman,Elanor N. Wainwright,Enid Y. N. Lam,Keely M. McDonald,Rachel Evans,Shihan Li,Daniel Rawlinson,Lachlan Dryburgh,Ali Zaid,Zoltan Maliga,Dominick Schienstock,Philippa Meiser,Hyun Jae Lee,Hongjin Lai,Marcela L. Moreira,Pirooz Zareie,Hye Young Lee
标识
DOI:10.1038/s41590-025-02347-9
摘要
CD8+ T cells are an important weapon in the therapeutic armamentarium against cancer. While CD8+CD103+ T cells with a tissue-resident memory T (TRM) cell phenotype are associated with favorable prognoses, the tumor microenvironment also contains dysfunctional exhausted T (TEX) cells that exhibit a variety of TRM-like features. Here we deconvolute TRM and TEX cells across human cancers, ascribing markers and gene signatures that distinguish these populations and enable their functional distinction. Although TRM cells have superior functionality and are associated with long-term survival post-tumor resection, they are not associated with responsiveness to immune checkpoint blockade. Tumor-associated TEX and TRM cells are clonally distinct, with the latter comprising tumor-independent bystanders and tumor-specific cells segregated from cognate antigen. Intratumoral TRM cells can be forced toward an exhausted fate when chronic antigen stimulation occurs, indicating that the presence or absence of continuous antigen exposure within the microenvironment is the key distinction between tumor-associated TEX and TRM populations. These results highlight unique functions for TRM and TEX cells in tumor control, underscoring the need for distinct strategies to harness these populations for cancer therapies.
科研通智能强力驱动
Strongly Powered by AbleSci AI